Drug Pipeline Quarterly Update: September 2021

Drugs in review, drugs with expiring patents, generic availability and more.

September 30, 2021

These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.

September 2021 Quarterly Drug Pipeline Update
September 2021 Quarterly Specialty Drug Pipeline Update

Related research

Drug pipeline updates

January 28, 2022

Drug Pipeline Update: January 2022

This monthly pipeline wrap up provides a review of newly approved drugs, recent…

Drug pipeline updates

January 26, 2022

Keytruda continues to stack up FDA approvals for more cancer indications

Since its first FDA approval in 2014, Merck’s Keytruda® (pembrolizumab) has been delivering…

Drug pipeline updates

January 13, 2022

February 2022 decisions expected from the FDA

At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…